Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.

Although chromosome 3p deletions are considered an initial event in clear cell renal cell carcinoma (RCC), the reported prevalence of 3p deletions is highly variable. Because molecular analyses may be influenced by intratumoral heterogeneity, this study was performed to evaluate the genetic heterogeneity of the von Hippel-Lindau (VHL) gene (on 3p25.5) in RCC. Fifty-three clear cell and papillary RCCs were examined by dual-labeling fluorescence in situ hybridization with probes for the VHL gene and chromosome 3 centromere. The results were compared with histopathological phenotype, proliferative activity (Ki-67 labeling index) and 8p/17p deletions (both suggested to be linked to RCC progression). A clear-cut VHL deletion (in more than 40% of cells) was detectable in 69% of clear cell RCCs but was not detectable in nine papillary RCCs. A considerable genetic heterogeneity of VHL deletions was seen in clear cell RCCs including VHL-deleted subpopulations with different chromosome 3 counts within individual tumors as well as populations with and without VHL deletions. 8p22 and 17p13 deletions (each of which were detected in 18% of clear cell RCCs) were both linked to VHL deletions. However, 8p and 17p deletions were not associated with tumor grade, stage, or Ki-67 labeling index. The data indicate that some clear cell RCCs may develop independently of VHL alterations.

[1]  R. Greenberg,et al.  Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. , 1995, Cancer research.

[2]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[3]  C. Cordon-Cardo,et al.  Allelic deletions in renal tumors: histopathological correlations. , 1993, Cancer research.

[4]  Y. Nakamura,et al.  A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. , 1991, Cancer research.

[5]  Y. Ahn,et al.  Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus , 1996, Molecular carcinogenesis.

[6]  F. Waldman,et al.  Complementarity of interphase and metaphase chromosome analysis in human renal tumors , 1993, Genes, chromosomes & cancer.

[7]  H. Brauch,et al.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.

[8]  F. Waldman,et al.  Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.

[9]  G. H. Weiss,et al.  Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. , 1991, Cancer research.

[10]  A. Sandberg,et al.  Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. , 1986, Cancer research.

[11]  S. Jhanwar,et al.  Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. , 1991, Cancer research.

[12]  U. Bergerheim,et al.  Deletion mapping in human renal cell carcinoma. , 1989, Cancer research.

[13]  P. Bugert,et al.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. , 1996, The American journal of pathology.

[14]  F. Waldman,et al.  EGF‐r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization , 1998, The Journal of pathology.

[15]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. McCue,et al.  Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. , 1995, Cancer research.

[17]  K. Huebner,et al.  Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. , 1994, Cancer research.

[18]  P. Carroll,et al.  Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. , 1994, The American journal of pathology.

[19]  D. Grignon,et al.  A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas. , 1996, Oncogene.

[20]  C. Wijmenga,et al.  The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB. , 1991, Genomics.

[21]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Nakamura,et al.  Specific genetic change in tumors associated with von Hippel-Lindau disease. , 1989, Journal of the National Cancer Institute.

[23]  A. Jauch,et al.  Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. , 1997, Cancer research.

[24]  F. Waldman,et al.  Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. , 1997, The American journal of pathology.

[25]  C. Buys,et al.  Loss of heterozygosity at the short arm of chromosome 3 in renal‐cell cancer correlates with the cytological tumour type , 1993, International journal of cancer.

[26]  R. Schinella,et al.  Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas. , 1988, Cancer research.

[27]  C. Buys,et al.  Involvement of multiple loci on chromosome 3 in renal cell cancer development , 1997, Genes, chromosomes & cancer.

[28]  A. Renshaw,et al.  Trisomy 3 in renal cell carcinoma. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.